Cambridge Investment Research Advisors, Inc.
Position in EXEL — Exelixis, Inc.
CIK 1419186
FAIRFIELD, IA
Position in EXEL
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$4,473,154
-$2,378,480 QoQ
Shares Held
82,212
-48.5% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#181
of 751 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $60,632,692 across 72 Biotechnology names. EXEL ranks #2 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,946 | $10,901,236 | |
| 2 | EXEL |
Exelixis, Inc.
This page
|
82,212 | $4,473,154 | |
| 3 | NKTR |
Nektar Therapeutics
|
56,186 | $3,922,344 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
35,157 | $3,056,901 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
15,839 | $2,966,327 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,591 | $2,862,672 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
46,210 | $2,520,293 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
30,727 | $2,288,546 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,473,154 | 82,212 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $6,851,634 | 159,749 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $3,751,059 | 85,582 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $8,058,703 | 195,126 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,797,139 | 86,142 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $3,104,676 | 84,092 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $2,294,669 | 68,909 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,898,468 | 150,230 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $3,548,125 | 157,905 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $3,682,255 | 155,173 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $3,980,060 | 165,905 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $295,739 | 13,535 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $266,871 | 13,965 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $788,201 | 40,608 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $261,548 | 16,306 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,661,123 | 105,939 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $402,471 | 19,331 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $605,606 | 26,714 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $516,830 | 28,273 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $596,803 | 28,231 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $639,995 | 35,126 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,546,209 | 112,714 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,708,418 | 85,123 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $1,708,345 | 69,871 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $1,518,339 | 63,957 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $1,114,030 | 64,694 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||